The role of the cancer stem cell marker CD271 in DNA damage response and drug resistance of melanoma cells
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of the cancer stem cell marker CD271 in DNA damage response and drug resistance of melanoma cells
Authors
Keywords
-
Journal
Oncogenesis
Volume 6, Issue 1, Pages e291-e291
Publisher
Springer Nature
Online
2017-01-23
DOI
10.1038/oncsis.2016.88
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibody Therapy Targeting CD47 and CD271 Effectively Suppresses Melanoma Metastasis in Patient-Derived Xenografts
- (2016) Michael Ngo et al. Cell Reports
- Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) R. Dummer et al. ANNALS OF ONCOLOGY
- Non-genetic cancer cell plasticity and therapy-induced stemness in tumour relapse: ‘What does not kill me strengthens me’
- (2015) A O Pisco et al. BRITISH JOURNAL OF CANCER
- Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cells
- (2015) Inna Zubrilov et al. CANCER LETTERS
- Temozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cells
- (2015) Jessian L. Munoz et al. CANCER LETTERS
- Specific chemotherapeutic agents induce metastatic behaviour through stromal- and tumour-derived cytokine and angiogenic factor signalling
- (2015) Guanghua Liu et al. JOURNAL OF PATHOLOGY
- BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies
- (2015) Francesco Spagnolo et al. OncoTargets and Therapy
- Organ-specific adaptive signaling pathway activation in metastatic breast cancer cells
- (2015) Riesa M. Burnett et al. Oncotarget
- Increased CD271 expression by the NF-kB pathway promotes melanoma cell survival and drives acquired resistance to BRAF inhibitor vemurafenib
- (2015) Abdelali Lehraiki et al. Cell Discovery
- B-Raf inhibitor vemurafenib in combination with temozolomide and fotemustine in the killing response of malignant melanoma cells
- (2015) Wynand P. Roos et al. Oncotarget
- NEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma
- (2015) Ye Yang et al. Oncotarget
- Novel genes associated with lymph node metastasis in triple negative breast cancer
- (2015) Andrea Mathe et al. Scientific Reports
- Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study
- (2014) A. M. Di Giacomo et al. ANNALS OF ONCOLOGY
- HMMR Maintains the Stemness and Tumorigenicity of Glioblastoma Stem-like Cells
- (2014) J. Tilghman et al. CANCER RESEARCH
- Molecular Profiling of Patient-Matched Brain and Extracranial Melanoma Metastases Implicates the PI3K Pathway as a Therapeutic Target
- (2014) G. Chen et al. CLINICAL CANCER RESEARCH
- Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
- (2014) Chong Sun et al. NATURE
- A stress-induced early innate response causes multidrug tolerance in melanoma
- (2014) D Ravindran Menon et al. ONCOGENE
- The Nerve Growth Factor Receptor CD271 Is Crucial to Maintain Tumorigenicity and Stem-Like Properties of Melanoma Cells
- (2014) Torben Redmer et al. PLoS One
- NEK2 Induces Drug Resistance Mainly through Activation of Efflux Drug Pumps and Is Associated with Poor Prognosis in Myeloma and Other Cancers
- (2013) Wen Zhou et al. CANCER CELL
- Overcoming Intrinsic Multidrug Resistance in Melanoma by Blocking the Mitochondrial Respiratory Chain of Slow-Cycling JARID1Bhigh Cells
- (2013) Alexander Roesch et al. CANCER CELL
- Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC
- (2013) Raffaele Addeo et al. Expert Opinion On Drug Safety
- Malignant melanoma cells acquire resistance to DNA interstrand cross-linking chemotherapeutics by p53-triggered upregulation of DDB2/XPC-mediated DNA repair
- (2013) C Barckhausen et al. ONCOGENE
- Upregulated expression of FGF13/FHF2 mediates resistance to platinum drugs in cervical cancer cells
- (2013) Tomoko Okada et al. Scientific Reports
- Mechanisms and insights into drug resistance in cancer
- (2013) Hiba Zahreddine et al. Frontiers in Pharmacology
- Fibroblast Growth Factor 13 Is a Microtubule-Stabilizing Protein Regulating Neuronal Polarization and Migration
- (2012) Qing-Feng Wu et al. CELL
- DNA repair and replication proteins as prognostic markers in melanoma
- (2012) Liang Song et al. HISTOPATHOLOGY
- SIFT web server: predicting effects of amino acid substitutions on proteins
- (2012) Ngak-Leng Sim et al. NUCLEIC ACIDS RESEARCH
- Chemotherapy Enhances Metastasis Formation via VEGFR-1-Expressing Endothelial Cells
- (2011) L. G. M. Daenen et al. CANCER RESEARCH
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
- (2010) Ramin Nazarian et al. NATURE
- Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271
- (2010) Alexander D. Boiko et al. NATURE
- MutationTaster evaluates disease-causing potential of sequence alterations
- (2010) Jana Marie Schwarz et al. NATURE METHODS
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- Gene Expression Changes in an Animal Melanoma Model Correlate with Aggressiveness of Human Melanoma Metastases
- (2008) L. Xu et al. MOLECULAR CANCER RESEARCH
- Transcriptional control of human p53-regulated genes
- (2008) Todd Riley et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
- (2008) Da Wei Huang et al. NUCLEIC ACIDS RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now